ERIN CODY: Open Payments
NPI 1720506389 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $1,084
Food & beverage: $985Education: $99
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $207 |
| Madrigal Pharmaceuticals | 3 | $171 |
| ABBVIE INC. | 12 | $161 |
| Janssen Biotech, Inc. | 4 | $145 |
| Regeneron Pharmaceuticals, Inc. | 1 | $127 |
| GENZYME CORPORATION | 3 | $91 |
| Lilly USA, LLC | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Ardelyx, Inc. | 1 | $24 |
| ORPHALAN INC | 1 | $24 |
Products named: DUPIXENT, ENTYVIO, REZDIFFRA, TREMFYA, LINZESS, OMVOH, VOQUEZNA, IBSRELA.
Industry payments across AZ — which companies pay providers there.
